Company news
Sunshine Biopharma Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Europe Until 2033
March 10, 2021
Sunshine Biopharma Receives Recently Ordered New Batch of Adva-27a and Initiates QA/QC Testing
March 3, 2021
Sunshine Biopharma Launches eCommerce Store for Its Science-Based Nutritional Supplements
February 28, 2021
Sunshine Biopharma Discusses the Progress of Its COVID-19 and Anticancer Compounds with The Stock Day Podcast
February 16, 2021
Sunshine Biopharma Initiates COVID-19 Treatment Mice Study
February 9, 2021
Sunshine Biopharma Signs Exclusive License Agreement With University of Georgia for COVID-19 Compounds
February 3, 2021
Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Canada Until 2033
February 1, 2021
Sunshine Biopharma Completes Application to Uplist to OTCQB
January 26, 2021
Sunshine Biopharma Receives Fourth Tranche From Previously Announced $2,000,000 + Financing for Coronavirus Treatment
January 13, 2021
Sunshine Biopharma’s Coronavirus Treatment Anticipated to Be Effective Against the New Variant Identified in the UK
December 21, 2020
Sunshine Biopharma Orders a New Batch of Adva-27a for Testing on TOPII Amplified Cancers
December 7, 2020
Sunshine Biopharma Pays Off Convertible Notes in Cash Preventing New Shares From Hitting the Market
December 2, 2020
Sunshine Biopharma Receives Third Tranche From Previously Announced $2,000,000 + Financing for Coronavirus Treatment
November 30, 2020
Sunshine Biopharma Believes That an Effective Coronavirus Treatment Continues to Be Necessary
November 23, 2020
Sunshine Biopharma Signs an Agreement with a Montreal-based Company to Advance the Development of Adva-27a Anticancer Compound
November 17, 2020
Sunshine Biopharma Signs an Agreement for Distribution of Essential-9(TM) in Asia and the Far East
November 9, 2020
Sunshine Biopharma Receives Second Tranche From Previously Announced $2,000,000 + Financing for Coronavirus Treatment
October 25, 2020
Sunshine Biopharma Identifies a Lead Anti-Coronavirus Compound
October 6, 2020
Sunshine Biopharma Secures $2,000,000 + Financing for Coronavirus Treatment
September 14, 2020
Sunshine Biopharma Completes the Synthesis of Four Potential Inhibitors of Coronavirus Protease
August 24, 2020
Sunshine Biopharma Files A Patent Application For A New Coronavirus COVID-19 Treatment
June 2, 2020
Sunshine Biopharma Receives Health Canada Approval for Essential Calcium-Vitamin D(TM) Supplement
November 5, 2019
Sunshine Biopharma Initiates Adva-27a Xenograft Studies in Mice Carrying Different Types of Human Cancer
October 16, 2019
Decks
- Investor Presentation (February 2022)
Investor deck · 15 slides · Feb 8, 2022